In our study, we demonstrated that MAPK1 is a target of miR-217 through luciferase reporter and qPCR assays and confirmed that circMAN2B2 promotes HCC cell proliferation through the miR-217/MAPK1 regulatory axis. The gene discussed is MAPK1; the disease is hepatocellular carcinoma.